AZR · Forms 3, 4, 5
Insider trades at Azora Therapeutics, Inc. (DE)
No open-market insider buys or sells at Azora Therapeutics, Inc. (DE) in the last 90 days; 5 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Azora Therapeutics, Inc. (DE) (AZR) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Coastlands Capital LP | 10% owner | Options or other derivatives | Form 4 | ||||
| Julie Saiki | Chief Strategy Officer | Became an insider (Form 3) | Form 3 | ||||
| Vassiliki Economides | Chief Financial Officer | Became an insider (Form 3) | Form 3 | ||||
| Matt Davidson | President and CEO | Award | 232,417 | Form 4 | |||
| Wendy B. Young | Director | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.